Rifampicin in cutaneous leishmaniasis – a therapeutic trial in Saudi Arabia. J Pak Assoc Dermatol [Internet]. 2017 Jan. 3 [cited 2026 Jun. 24];16(1):4-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/838